Risks

Higher net debt and interest coverage pressure versus specialty-ingredient peers can constrain flexibility if volumes soften or refinancing costs stay elevated.

A 92.7-day cash conversion cycle versus leaner peers ties up working capital, limiting free-cash-flow conversion and amplifying demand volatility.

Inventory days near 88 and receivables above 66 days increase exposure to customer destocking and slower cash realization relative to faster-turn peers.

Moderate leverage can leave IFF less resilient than larger diversified peers if input-cost inflation or end-market weakness delays margin recovery.

Opportunities

A current ratio above 2.0 and quick ratio near 1.7 give IFF more liquidity headroom than many ingredient peers, supporting execution through cyclical demand swings.

IFF’s scale in flavors, fragrances, and biosciences can capture resilient demand from consumer-staples and health-oriented customers better than narrower peers.

Working-capital normalization could lift cash generation meaningfully if inventory and receivables improve, creating upside versus peers with already efficient conversion.

Diversified end-market exposure can soften category-specific weakness and preserve pricing power better than more concentrated specialty-chemical competitors.

Overall Score

IFF’s liquidity and diversified end-market exposure support a solid forward position, while leverage and working-capital intensity remain the main constraints versus peers.